Ampio Pharmaceuticals Inc (AMPE)
0.286
-0.06
(-16.13%)
USD |
OTCM |
Apr 23, 16:00
Ampio Pharmaceuticals Cash from Operations (TTM): -8.564M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -8.564M |
| September 30, 2023 | -10.55M |
| June 30, 2023 | -15.94M |
| March 31, 2023 | -18.48M |
| December 31, 2022 | -21.13M |
| September 30, 2022 | -20.54M |
| June 30, 2022 | -18.50M |
| March 31, 2022 | -14.89M |
| December 31, 2021 | -14.09M |
| September 30, 2021 | -13.26M |
| June 30, 2021 | -12.06M |
| March 31, 2021 | -14.32M |
| December 31, 2020 | -14.73M |
| September 30, 2020 | -16.60M |
| June 30, 2020 | -18.63M |
| March 31, 2020 | -17.50M |
| December 31, 2019 | -15.38M |
| September 30, 2019 | -12.96M |
| June 30, 2019 | -11.43M |
| March 31, 2019 | -10.98M |
| December 31, 2018 | -12.14M |
| September 30, 2018 | -12.38M |
| June 30, 2018 | -12.30M |
| March 31, 2018 | -12.39M |
| December 31, 2017 | -11.41M |
| Date | Value |
|---|---|
| September 30, 2017 | -11.42M |
| June 30, 2017 | -10.78M |
| March 31, 2017 | -12.36M |
| December 31, 2016 | -14.62M |
| September 30, 2016 | -19.81M |
| June 30, 2016 | -23.56M |
| March 31, 2016 | -24.32M |
| December 31, 2015 | -26.44M |
| September 30, 2015 | -24.44M |
| June 30, 2015 | -24.95M |
| March 31, 2015 | -29.26M |
| December 31, 2014 | -30.74M |
| September 30, 2014 | -29.98M |
| June 30, 2014 | -28.62M |
| March 31, 2014 | -24.01M |
| December 31, 2013 | -19.13M |
| September 30, 2013 | -16.73M |
| June 30, 2013 | -13.24M |
| March 31, 2013 | -10.21M |
| December 31, 2012 | -9.715M |
| September 30, 2012 | -11.25M |
| June 30, 2012 | -10.87M |
| March 31, 2012 | -10.45M |
| December 31, 2011 | -9.132M |
| September 30, 2011 | -5.743M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-21.13M
Minimum
Dec 2022
-8.564M
Maximum
Dec 2023
-15.24M
Average
-14.89M
Median
Mar 2022
Cash from Operations (TTM) Benchmarks
| NeuBase Therapeutics Inc | -14.78M |
| Tivic Health Systems Inc | -8.511M |
| Oragenics Inc | -7.291M |
| Actinium Pharmaceuticals Inc | -47.34M |
| MAIA Biotechnology Inc | -13.07M |